Navigation Links
Beta-Pro Expands Operations to Meet Demands for Human Cells in Hepatocyte Drug Discovery Market
Date:10/12/2010

CHARLOTTESVILLE, Va., Oct. 12 /PRNewswire/ -- Beta-Pro LLC, announced today that it has expanded its operations to accommodate increasing demands from pharmaceutical drug discovery and research institutes in the $2 billion hepatocyte market. The human cellular sciences company now manages extensive laboratory facilities in the University of Virginia Research Park in Charlottesville, Virginia.  

"Beta-Pro has already established a foothold in the human pancreatic islet cell market and has consistently been able to supply diabetes researchers and transplant centers with high-quality, clinical and transplantable human islets and other pancreatic biomaterials," said Beta-Pro Principle Scientific Advisor and Professor of Surgery at the University of Virginia, Kenneth L. Brayman, M.D., Ph.D.  "Based on our success we are now broadening the focus of our cellular services to include liver biology and the needs of pharmaceutical companies in testing drugs in human hepatocyte-cell cultures."

Beta-Pro partners with leading pharmaceutical companies and research organizations including: Pfizer, Eli Lilly, Genentech, Merck, Genomics Institute of the Novartis Research Foundation (GNF), and The Broad Institute in Cambridge, Massachusetts. Beta-Pro's new laboratory is designated as a good laboratory practice (GLP) facility and is now fully operational. The company has moved its snap-frozen cell bank to the new location and will use the facility to focus on hepatocytes and other human cell applications, including drug discovery services and toxicology screening using human cells.

About Beta-ProBeta-Pro isolates and distributes human pancreatic islet cells, acinar tissue, hepatocytes, adipose-derived stem cells, mesenchymal stem cells, and other biomaterials from surplus organs not placed for whole organ transplant in GMP and GLP facilities. The company also offers custom drug discovery and toxicology testing services using human cells for potential pharmacological applications. Beta-Pro charges and recovers fees for the costs for organ procurement, processing, preservation, quality control, storage, handling, and delivery of islets, other biomaterials, and biological data. For more information, call (434) 973-9456 or visit www.betaprolabs.com. Contact:

John Kelly PR(434) 296-5577john@johnkellypr.com
'/>"/>

SOURCE Beta-Pro LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Beta-Pro Donates Human Islet Cells to Diabetes Researcher
2. MicuRx Pharmaceuticals Selects Next-Generation Antibiotic Candidate Targeting MRSA and Expands Operation in China
3. Hoya Vision Care Expands in Czech Republic
4. Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare
5. InVitria Expands Sales Team
6. Enerkem Expands Executive Management Team
7. PSKW Expands Its Lawsuit Against McKesson to Seek Assignment of McKessons Patent Application
8. Supelco(R) Expands Ascentis(R) Express HPLC Columns Line for High-Speed and High-Efficiency Separations
9. BioElectronics Corp Aggressively Expands Sales into Middle East
10. Quintiles Expands Base for Growing Asia-Pacific Operations
11. CryoLife Expands Distribution of Hemostase MPH(R) to France through Laboratoire Gamida
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... and READING, England , ... Indegene ( http://www.indegene.com ), ein führender Anbieter ... die Life-Science-Branche, Pharmaunternehmen und Gesundheitsorganisationen, und TranScrip ... von innovativen wissenschaftlichen Support-Services für den gesamten ... IntraScience heute den Ausbau ihrer bestehenden Allianz ...
(Date:5/26/2016)... Despite the volatility that continues to ... Today,s pre-market research on ActiveWallSt.com directs the investor community,s focus ... RDUS ), Cerus Corp. (NASDAQ: CERS ), ... Prime Therapeutics Inc. (NASDAQ: FPRX ). Register with ... http://www.activewallst.com/ On Wednesday, shares in ...
(Date:5/25/2016)... ... May 25, 2016 , ... Thailand’s Board of Investment’s New ... San Francisco. Located at booth number 7301, representatives from the Thai Government, research ... the Thai biotechnology and life sciences sector. , Deputy Secretary General of ...
(Date:5/25/2016)... ... May 25, 2016 , ... WEDI, the nation’s leading authority on the ... Charles W. Stellar has been named by the WEDI Board of Directors as WEDI’s ... an executive leader with more than 35 years of experience in healthcare, association management ...
Breaking Biology Technology:
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
(Date:3/22/2016)... 22, 2016 According ... Market for Consumer Industry by Type (Image, Motion, ... (Communication & IT, Entertainment, Home Appliances, & ... to 2022", published by MarketsandMarkets, the market ... reach USD 26.76 Billion by 2022, at ...
(Date:3/21/2016)... , March 22, 2016 ... with passcodes for superior security   ... leading provider of secure digital communications services, today announced ... technology and offer enterprise customers, particularly those in the ... recognition and voice authentication within a mobile app, alongside, ...
Breaking Biology News(10 mins):